Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Apogee Minerals Announces Amendment to Option Agreement for the Pine Channel Property
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
-
Shapeways Reports Fourth Quarter and Full Year 2023 Results
-
Nokia Corporation: Repurchase of own shares on 28.03.2024
-
Par Pacific Announces Expected Term Loan Repricing
-
Maui Land & Pineapple Company Reports Fiscal 2023 Results
-
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
-
Springbig Launches '20 Days of 4/20' Campaign to Empower Cannabis Dispensaries with Customer Retention Strategies
-
Springbig Launches '20 Days of 4/20' Campaign to Empower Cannabis Dispensaries with Customer Retention Strategies
-
NaaS Technology Inc. Reports Unaudited 2023 Fourth Quarter and Full Year Financial Results
-
Reed’s Reports Fourth Quarter and Full Year 2023 Results and Issues 2024 Financial Outlook
-
Wintrust Financial Corporation Announces First Quarter 2024 Earnings Release Schedule
-
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
-
Canoe Financial proposes changes to Canoe Premium Income Fund
-
California Water Service Group Recognized by Newsweek as One of “America’s Most Trustworthy Companies”
-
Eagle Bancorp, Inc. Announces Cash Dividend
-
Armada Hoffler to Discuss First Quarter Earnings on May 9th
-
IB Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering, Including Full Exercise of Underwriter Over-Allotment Option
-
Ryman Hospitality Properties, Inc. Announces Closing of $1.0 Billion of 6.500% Senior Notes Due 2032
-
OLIVELA Fashions A Better Future for Women and the Luxury Fashion Industry This Women’s History Month
-
KFC Canada Does it Again and Launches ‘$4.95 Fill Up’- Quality Meals at an Unbeatable Price
-
AGBA Announces Fourth Quarter 2023 Earnings, Amid Challenging Macro Environment.
-
CEA Industries Inc. Reports Fourth Quarter and Full Year 2023 Results
-
Power Solutions International Announces Extension to Credit Agreement
-
Forian Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
-
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth-Quarter and Full-Year Fiscal 2023 Results; Posts 11% Annual Sales Growth; Announces 3% Increase in Quarterly Dividend
-
Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
-
TPI Composites, Inc. Publishes its Annual Sustainability Report Reaffirming Its Commitments to a Zero-Harm Culture and Carbon Neutrality
-
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
-
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
-
ASML cautions investors regarding Tutanota LLC’s “mini-tender” offer
-
ArriVent BioPharma Reports Full Year 2023 Financial Results
-
CervoMed to Participate in Upcoming Investor Conferences
-
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
-
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
-
Dorchester Minerals, L.P. Announces Acquisition of Mineral Interests
-
Sharecare announces fourth quarter and full year 2023 financial results and operational highlights
-
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights
-
Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
-
Dime Community Bancshares Declares Quarterly Cash Dividend for Common Stock
-
Global-e Announces Filing of Form 20-F for the Fiscal Year Ended December 31, 2023
-
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
-
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
-
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
-
CGRA Announces Completion and Publication of 2023 Annual Disclosure
-
Acuity Brands Declares Quarterly Dividend
-
Ardelyx, Inc. Reports Employment Inducement Grants
-
Leading Proxy Advisory Firms Recommend ContextLogic Stockholders Vote “FOR” Pending Transaction with Qoo10

